Phase 2b/3 study of Cinquil for pediatric eosinophilic esophagitis (EoE)
Ception Therapeutics and Cephalon announced results from a Phase 2b/3 clinical trial for Cinquil (reslizumab) as a treatment for pediatric eosinophilic esophagitis.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.